<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35034092</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-5438</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>30</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>European journal of human genetics : EJHG</Title>
          <ISOAbbreviation>Eur J Hum Genet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Bi-allelic SMO variants in hypothalamic hamartoma: a recessive cause of Pallister-Hall syndrome.</ArticleTitle>
        <Pagination>
          <StartPage>384</StartPage>
          <EndPage>388</EndPage>
          <MedlinePgn>384-388</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41431-021-01023-4</ELocationID>
        <Abstract>
          <AbstractText>Pallister-Hall syndrome, typically caused by germline or de novo variants within the GLI3 gene, has key features of hypothalamic hamartoma and polydactyly. Recently, a few similar cases have been described with bi-allelic SMO variants. We describe two siblings born to non-consanguineous unaffected parents presenting with hypothalamic hamartoma, post-axial polydactyly, microcephaly amongst other developmental anomalies. Previous clinical diagnostic exome analysis had excluded a pathogenic variant in GLI3. We performed exome sequencing re-analysis and identified bi-allelic SMO variants including a missense and synonymous variant in both affected siblings. We functionally characterised this synonymous variant showing it induces exon 8 skipping within the SMO transcript. Our results confirm bi-allelic SMO variants as an uncommon cause of Pallister-Hall syndrome and describe a novel exon-skipping mechanism, expanding the molecular architecture of this new clinico-molecular disorder.</AbstractText>
          <CopyrightInformation>© 2021. The Author(s), under exclusive licence to European Society of Human Genetics.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Green</LastName>
            <ForeName>Timothy E</ForeName>
            <Initials>TE</Initials>
            <AffiliationInfo>
              <Affiliation>Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Vic, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schimmel</LastName>
            <ForeName>Mareike</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital, University Hospital Augsburg, Augsburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schubert</LastName>
            <ForeName>Susanna</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Human Genetics, University of Leipzig Medical Centre, Leipzig, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lemke</LastName>
            <ForeName>Johannes R</ForeName>
            <Initials>JR</Initials>
            <Identifier Source="ORCID">0000-0002-4435-6610</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Human Genetics, University of Leipzig Medical Centre, Leipzig, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bennett</LastName>
            <ForeName>Mark F</ForeName>
            <Initials>MF</Initials>
            <AffiliationInfo>
              <Affiliation>Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Vic, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Vic, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medical Biology, University of Melbourne, Melbourne, Vic, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Hildebrand</LastName>
            <ForeName>Michael S</ForeName>
            <Initials>MS</Initials>
            <Identifier Source="ORCID">0000-0003-2739-0515</Identifier>
            <AffiliationInfo>
              <Affiliation>Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Vic, Australia. michael.hildebrand@unimelb.edu.au.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Neuroscience Research Group, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Vic, Australia. michael.hildebrand@unimelb.edu.au.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Berkovic</LastName>
            <ForeName>Samuel F</ForeName>
            <Initials>SF</Initials>
            <Identifier Source="ORCID">0000-0003-4580-841X</Identifier>
            <AffiliationInfo>
              <Affiliation>Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Vic, Australia. s.berkovic@unimelb.edu.au.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Eur J Hum Genet</MedlineTA>
        <NlmUniqueID>9302235</NlmUniqueID>
        <ISSNLinking>1018-4813</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C491023">SMO protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000072086">Smoothened Receptor</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C537158">Hypothalamic hamartomas</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006222" MajorTopicYN="Y">Hamartoma</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007027" MajorTopicYN="Y">Hypothalamic Diseases</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054975" MajorTopicYN="Y">Pallister-Hall Syndrome</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017689" MajorTopicYN="Y">Polydactyly</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000072086" MajorTopicYN="N">Smoothened Receptor</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>3</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>16</Day>
          <Hour>21</Hour>
          <Minute>11</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35034092</ArticleId>
        <ArticleId IdType="pmc">PMC8904774</ArticleId>
        <ArticleId IdType="doi">10.1038/s41431-021-01023-4</ArticleId>
        <ArticleId IdType="pii">10.1038/s41431-021-01023-4</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Khawaja AM, Pati S, Ng Y-T. Topical review: management of epilepsy due to hypothalamic hamartomas. Pediatr Neurol. 2017;75:29–42. doi: 10.1016/j.pediatrneurol.2017.07.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pediatrneurol.2017.07.001</ArticleId>
            <ArticleId IdType="pubmed">28886982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biesecker LG. Pallister-Hall syndrome In: GeneReviews. University of Washington, Seattle; 1993-2021. 2000 [updated May 18th 2017]. https://www.ncbi.nlm.nih.gov/books/NBK1465/?report=classic. Accessed 27 July 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Johnston JJ, Olivos-Glander I, Killoran C, Elson E, Turner JT, Peters KF, et al.  Molecular and clinical analyses of Greig Cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations. Am J Hum Genet. 2005;76:609–22. doi: 10.1086/429346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/429346</ArticleId>
            <ArticleId IdType="pmc">PMC1199298</ArticleId>
            <ArticleId IdType="pubmed">15739154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang S, Graham JM, Jr., Olney AH, Biesecker L. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat Genet. 1997;15:266–8. doi: 10.1038/ng0397-266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng0397-266</ArticleId>
            <ArticleId IdType="pubmed">9054938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonnard C, Shboul M, Tonekaboni SH, Ng AYJ, Tohari S, Ghosh K, et al.  Novel mutations in the ciliopathy-associated gene CPLANE1 (C5orf42) cause OFD syndrome type VI rather than Joubert syndrome. Eur J Hum Genet. 2018;61:585–95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29605658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez E, Thauvin-Robinet C, Reversade B, Khartoufi NE, Devisme L, Holder M, et al.  C5orf42 is the major gene responsible for OFD syndrome type VI. Hum Genet. 2014;133:367–77. doi: 10.1007/s00439-013-1385-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00439-013-1385-1</ArticleId>
            <ArticleId IdType="pubmed">24178751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rubino S, Qian J, Pinheiro-Neto CD, Kenning TJ, Adamo MA. A familial syndrome of hypothalamic hamartomas, polydactyly, and SMO mutations: a clinical report of 2 cases. J Neurosurg Pediatr. 2019: 98-103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30497210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le T-L, Sribudiani Y, Dong X, Huber C, Kois C, Baujat G, et al.  Bi-allelic variations of SMO in humans cause a broad spectrum of developmental anomalies due to abnormal hedgehog signaling. Am J Hum Genet. 2020;106:779–92. doi: 10.1016/j.ajhg.2020.04.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2020.04.010</ArticleId>
            <ArticleId IdType="pmc">PMC7273534</ArticleId>
            <ArticleId IdType="pubmed">32413283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valdueza JM, Cristante L, Dammann O, Bentele K, Vortmeyer A, Saeger W, et al.  Hypothalamic hamartomas: with special reference to gelastic epilepsy and surgery. Neurosurgery. 1994;34:949–58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8084405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30. doi: 10.1093/nar/28.1.27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/28.1.27</ArticleId>
            <ArticleId IdType="pmc">PMC102409</ArticleId>
            <ArticleId IdType="pubmed">10592173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q, et al.  The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434–43. doi: 10.1038/s41586-020-2308-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-020-2308-7</ArticleId>
            <ArticleId IdType="pmc">PMC7334197</ArticleId>
            <ArticleId IdType="pubmed">32461654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Desmet F-O, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67. doi: 10.1093/nar/gkp215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkp215</ArticleId>
            <ArticleId IdType="pmc">PMC2685110</ArticleId>
            <ArticleId IdType="pubmed">19339519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Burge CB. Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA. 2008;14:802–13. doi: 10.1261/rna.876308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1261/rna.876308</ArticleId>
            <ArticleId IdType="pmc">PMC2327353</ArticleId>
            <ArticleId IdType="pubmed">18369186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christian LL, Eric H, Elliot JA, Brunhilde W, Single A. Nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA. 1999;96:6307–11. doi: 10.1073/pnas.96.11.6307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.96.11.6307</ArticleId>
            <ArticleId IdType="pmc">PMC26877</ArticleId>
            <ArticleId IdType="pubmed">10339583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M, Lu X, Dong J, Yao Z, Wu Y, Rao H, et al.  A synonymous mutation in exon 39 of FBN1 causes exon skipping leading to Marfan syndrome. Genomics. 2020;112:3856–61. doi: 10.1016/j.ygeno.2020.06.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ygeno.2020.06.024</ArticleId>
            <ArticleId IdType="pubmed">32562828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li N, Xu Y, Yu T, Yao R, Chen J, Luo C, et al.  Further delineation of bone marrow failure syndrome caused by novel compound heterozygous variants of MYSM1. Gene. 2020;757:144938. doi: 10.1016/j.gene.2020.144938.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gene.2020.144938</ArticleId>
            <ArticleId IdType="pubmed">32640305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliveira J, Soares-Silva I, Fokkema I, Gonçalves A, Cabral A, Diogo L, et al.  Novel synonymous substitution in POMGNT1 promotes exon skipping in a patient with congenital muscular dystrophy. J Hum Genet. 2008;53:565–72. doi: 10.1007/s10038-008-0263-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10038-008-0263-5</ArticleId>
            <ArticleId IdType="pubmed">18330676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corbit KC, Aanstad P, Singla V, Norman AR, Stainier DYR, Reiter JF. Vertebrate smoothened functions at the primary cilium. Nature. 2005;437:1018–21. doi: 10.1038/nature04117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature04117</ArticleId>
            <ArticleId IdType="pubmed">16136078</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
